Avapritinib Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 25 mg, 100 mg, 200 mg

Reference Brands: Ayvakyt (USA/EU)

Category: Oncology Cancer Care

Avapritinib is a targeted oncology therapy used to treat gastrointestinal stromal tumors (GIST) with PDGFRA exon 18 mutations. It works by inhibiting mutant tyrosine kinases, slowing tumor growth and controlling disease progression. Available as oral capsules in strengths of 25 mg, 100 mg, and 200 mg, Avapritinib is typically administered once daily under specialist supervision. Avapritinib is available in Capsules and strengths such as 25 mg, 100 mg, 200 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Avapritinib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Avapritinib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.